TYMS and colorectal carcinoma: As well as providing the sole intracellular source of thymidine for DNA synthesis [14], TS is also a target for a number of drugs used for CRC treatment, including 5-fluorouracil (5FU), whose mechanism of action is primarily mediated through competitive TS inhibition.